Major adverse cardiac events at 30 days and one year
| SES (n = 186) | PES (n = 136) | p Value* | |
|---|---|---|---|
| *By Fisher’s exact test. | |||
| re-MI, reinfarction; TLR, target lesion revascularisation; TVR, target vessel revascularisation. | |||
| 0–1 month | |||
| Death | 5.9% | 5.9% | 1.0 |
| Death or re-MI | 6.5% | 6.6% | 1.0 |
| TLR | 1.1% | 4.4% | 0.07 |
| TVR | 1.1% | 5.1% | 0.04 |
| Death, re-MI, or TVR | 7.5% | 10.3% | 0.4 |
| Stent thrombosis | 0% | 2.9% | 0.03 |
| 0–12 months | |||
| Death | 8.1% | 8.1% | 1.0 |
| Death or re-MI | 9.2% | 10.3% | 0.7 |
| TLR | 1.1% | 5.9% | 0.02 |
| TVR | 1.1% | 6.6% | 0.01 |
| Death, re-MI, or TVR | 9.7% | 14.7% | 0.22 |
| Stent thrombosis | 0% | 2.9% | 0.03 |